Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL4193055 | 0.95 | — | — | |
| Oxalic Acid SCHEMBL7522001 | 0.95 | — | — | |
| Oxalic Acid SCHEMBL337153 | 0.95 | — | — | |
| Oxalic Acid SCHEMBL106863 | 0.95 | — | — | |
| Oxalic Acid SCHEMBL4871484 | 0.91 | — | — | |
| Oxalic Acid SCHEMBL23803723 | 0.90 | CA4 (0.50) | — | |
| Oxalic Acid SCHEMBL1698277 | 0.90 | CA4 (0.50) | — | |
| Oxalic Acid SCHEMBL104229 | 0.90 | — | — | |
| Oxalic Acid SCHEMBL6840041 | 0.90 | — | — | |
| Oxalic Acid SCHEMBL20553206 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3777856-B1 | HYDROPHILIC BERBERINE-TYPE DERIVATIVE AND APPLICATION THEREOF IN PREPARING DRUG | INST MATERIA MEDICA CAMS (CN) | 2022-02-09 | — | — | EP | claimed |
| EP-3390421-B1 | METAL COMPLEXES | UNIV LEEDS INNOVATIONS LTD (GB) | 2020-01-29 | — | — | EP | claimed |
| EP-1747188-B1 | METHOD FOR THE PRODUCTION OF LONG-CHAINED QUATERNARY AMMONIUM OXALATES AND AMMONIUM HYDROGENOXALATES | CLARIANT PRODUKTE DEUTSCHLAND (DE) | 2015-07-08 | — | — | EP | claimed |
| EP-2114118-B1 | SAFEGUARDING SEED SAFETY OF TREATED SEEDS | BAYER CROPSCIENCE AG (DE) | 2012-09-12 | — | — | EP | claimed |
| EP-0210885-B1 | DERIVATIVES OF PRIMARY HALOBIPHENYL ALCOHOLS THERAPEUTICALLY USEFUL IN THE TREATMENT OF ARTERIOSCLEROSIS | PIERRE FABRE MEDICAMENT (FR) | 1990-07-11 | — | — | EP | claimed |
| EP-0210885-A1 | Derivatives of primary halobiphenyl alcohols therapeutically useful in the treatment of arteriosclerosis | PIERRE FABRE MEDICAMENT (FR) | 1987-02-04 | — | — | EP | claimed |
| EP-0000825-B1 | GEMINALLY DISUBSTITUTED INDENE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Kabi AB (SE) | 1982-04-14 | — | — | EP | claimed |
| WO-2024054973-A3 | TRYPTAMINE DERIVATIVES | CAAMTECH, INC (US) | 2024-04-18 | — | — | WO | disclosed |
| WO-2024054973-A2 | TRYPTAMINE DERIVATIVES | CAAMTECH, INC (US) | 2024-03-14 | — | — | WO | disclosed |
| EP-0760811-A1 | IMIDAZOLE DERIVATIVES AS HISTAMINE RECEPTOR H 3? (ANT)AGONISTS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1997-03-12 | — | — | EP | disclosed |
| WO-1996029315-A2 | IMIDAZOLE DERIVATIVES AS HISTAMINE RECEPTOR H3 (ANT)AGONISTS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 1996-09-26 | — | — | WO | disclosed |
| EP-0210885-B1 | DERIVATIVES OF PRIMARY HALOBIPHENYL ALCOHOLS THERAPEUTICALLY USEFUL IN THE TREATMENT OF ARTERIOSCLEROSIS | PIERRE FABRE MEDICAMENT (FR) | 1990-07-11 | — | — | EP | disclosed |
| EP-0210885-A1 | Derivatives of primary halobiphenyl alcohols therapeutically useful in the treatment of arteriosclerosis | PIERRE FABRE MEDICAMENT (FR) | 1987-02-04 | — | — | EP | disclosed |